Dover has entered right into a definitive settlement to accumulate Malema Engineering Corp, a US designer and manufacturer of high-precision, mission-critical flow-measurement and control instruments for the biopharmaceutical, semiconductor and industrial sectors.
ราคาpressuregauge will broaden Dover’s biopharma single-use manufacturing providing, which already includes Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in Boca Raton, Florida, and with services in San Jose, California, Singapore, South Korea and India, Malema expects to generate roughly US$40 million–45 million in income in the course of the full 12 months 2022.
When the deal closes, Malema will turn into part of the PSG business unit inside Dover’s Pumps & Process Solutions section.
“We see a tremendous long-term growth alternative within the bioprocessing industry driven by a robust and growing pipeline of effective novel biologic drugs, biosimilars, protein therapies, non-COVID mRNA vaccines, as well as budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, the growing adoption of extra efficient single-use production processes supports a strong outlook for our offerings of single-use parts to end-customers. We imagine that pairing Malema’s expertise with our present portfolio of single-use pumps for biopharma processing will significantly improve the accuracy and worth proposition of our solutions to our customers.”
“We are methodically building out our biopharma platform through proactive capability additions, new product improvement, and opportunistic acquisitions of highly-attractive niche component technologies,” stated Richard Tobin, president and CEO of Dover. “Malema represents a strategic and highly-complementary flow-control and sensing expertise and further strengthens our sensor portfolio with new proprietary know-how. In addition to engaging biopharma applications, we expect robust growth in the semiconductor area on the capability expansion and re-shoring tailwinds.”
Share